1,437
Views
0
CrossRef citations to date
0
Altmetric
Bone-Mineral and Electrolyte Disorders

The association between bone density of lumbar spines and different daily protein intake in different renal function

, , , &
Article: 2298080 | Received 13 Jul 2023, Accepted 18 Dec 2023, Published online: 08 Jan 2024

References

  • Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):1–11. doi: 10.1007/s00198-012-2074-y.
  • Bihuniak JD, Insogna KL. The effects of dietary protein and amino acids on skeletal metabolism. Mol Cell Endocrinol. 2015;410:78–86. doi: 10.1016/j.mce.2015.03.024.
  • Rizzoli R, Stevenson JC, Bauer JM, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79(1):122–132. doi: 10.1016/j.maturitas.2014.07.005.
  • Medicine IO. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington (DC): The National Academies Press; 2005.
  • Bonjour JP. Nutritional disturbance in acid-base balance and osteoporosis: a hypothesis that disregards the essential homeostatic role of the kidney. Br J Nutr. 2013;110(7):1168–1177. doi: 10.1017/S0007114513000962.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, ­classification, and stratification. Am J Kidney Dis. 2002;39(2):S1–S266.
  • Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009;53(3):S4–S16. doi: 10.1053/j.ajkd.2008.07.048.
  • Denic A, Glassock RJ, Rule AD. Single-Nephron glomerular filtration rate in healthy adults. N Engl J Med. 2017;377(12):1203–1204. doi: 10.1056/NEJMc1709128.
  • Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996;49(6):1774–1777. doi: 10.1038/ki.1996.265.
  • Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med. 2017;377(18):1765–1776. doi: 10.1056/NEJMra1700312.
  • Garneata L, Stancu A, Dragomir D, et al. Ketoanalogue-Supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol. 2016;27(7):2164–2176. doi: 10.1681/ASN.2015040369.
  • Taguma Y, Kitamoto Y, Futaki G, et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med. 1985;313(26):1617–1620. doi: 10.1056/nejm198512263132601.
  • Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med. 1993;329(20):1456–1462. doi: 10.1056/nejm199311113292004.
  • Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–860. doi: 10.1056/NEJMoa011303.
  • Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–869. doi: 10.1056/NEJMoa011161.
  • Parving HH, Lehnert H, Bröchner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870–878. doi: 10.1056/NEJMoa011489.
  • Ruggenenti P, Fassi A, Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351(19):1941–1951. doi: 10.1056/NEJMoa042167.
  • Erratum. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes-2016. Diabetes Care. 2016;39(Suppl. 1):S13–S22. doi: 10.2337/dc16-er09.
  • Heerspink HJL, Parving H-H, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10184):1937–1947. doi: 10.1016/s0140-6736(19)30772-x.
  • Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219–2229. doi: 10.1056/NEJMoa2025845.
  • Ruilope LM, Agarwal R, Anker SD, et al. Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial. Am J Nephrol. 2019;50(5):345–356. doi: 10.1159/000503712.
  • van Baar MJB, van der Aart AB, Hoogenberg K, et al. The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists. Ther Adv Endocrinol Metab. 2019;10:2042018819865398. 2042018819865398 doi: 10.1177/2042018819865398.
  • Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70(10):1694–1705. doi: 10.1038/sj.ki.5001794.
  • Kontessis P, Jones S, Dodds R, et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int. 1990;38(1):136–144. doi: 10.1038/ki.1990.178.
  • Hahn D, Hodson EM, Fouque D. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev. 2006;10(10):CD001892. doi: 10.1002/14651858.CD001892.pub2.
  • Beto JA, Ramirez WE, Bansal VK. Medical nutrition therapy in adults with chronic kidney disease: integrating evidence and consensus into practice for the generalist registered dietitian nutritionist. J Acad Nutr Diet. 2014;114(7):1077–1087. doi: 10.1016/j.jand.2013.12.009.
  • K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(6 Suppl 2):S17–S104. doi: 10.1053/ajkd.2000.v35.aajkd03517.
  • Wu C-H, Yang Y-W, Hung S-C, et al. Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease. PloS One. 2017;12(5):e0176847. doi: 10.1371/journal.pone.0176847.
  • Yen C-L, Tu K-H, Lin M-S, et al. Does a supplemental low-protein diet decrease mortality and adverse events after commencing dialysis? A nationwide cohort study. Nutrients. 2018;10(8):1035. doi: 10.3390/nu10081035.
  • Update, Improving Global Outcomes KDIGO CKD-MBD. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59. doi: 10.1016/j.kisu.2017.04.001.
  • Lee CL, Tsai SF. The impact of protein diet on bone density in people with/without chronic kidney disease: an analysis of the national health and nutrition examination survey database. Clin Nutr. 2020;39(11):3497–3503. doi: 10.1016/j.clnu.2020.03.014.
  • Tsuji K, Kitamura M, Chiba K, et al. Comparison of bone microstructures via high-resolution peripheral quantitative computed tomography in patients with different stages of chronic kidney disease before and after starting hemodialysis. Rental Fail. 2022;44(1):381–391. doi: 10.1080/0886022x.2022.2043375.
  • Pimentel A, Ureña-Torres P, Zillikens MC, et al. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int. 2017;92(6):1343–1355. doi: 10.1016/j.kint.2017.07.021.
  • Huang J-F, Zheng X-Q, Sun X-L, et al. Association between bone mineral density and severity of chronic kidney disease. Int J Endocrinol. 2020;2020;2020:8852690. doi: 10.1155/2020/8852690.
  • Wolfe RR, Cifelli AM, Kostas G, et al. Optimizing protein intake in adults: interpretation and application of the recommended dietary allowance compared with the acceptable macronutrient distribution range. Adv Nutr. 2017;8(2):266–275. doi: 10.3945/an.116.013821.
  • Deutz NEP, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr. 2014;33(6):929–936. doi: 10.1016/j.clnu.2014.04.007.
  • Mitch WE. Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency. J Am Soc Nephrol. 1991;2(4):823–831. doi: 10.1681/ASN.V24823.
  • Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the modification of diet in renal disease study. Kidney Int. 1997;52(3):778–791. doi: 10.1038/ki.1997.395.
  • Aparicio M, Chauveau P, Précigout VD, et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol. 2000;11(4):708–716. doi: 10.1681/ASN.V114708.
  • Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;84(3):622–623. doi: 10.1038/ki.2013.243.
  • Looker AC, Melton LJ, Harris T, et al. Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int. 2009;20(7):1141–1149. doi: 10.1007/s00198-008-0809-6.
  • Ma Y-C, Zuo L, Chen J-H, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi: 10.1681/ASN.2006040368.
  • Rigalleau V, Lasseur C, Raffaitin C, et al. Glucose control influences glomerular filtration rate and its prediction in diabetic subjects. Diabetes Care. 2006;29(7):1491–1495. doi: 10.2337/dc06-0407.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
  • Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012;156(11):785–795. doi: 10.7326/0003-4819-156-6-201203200-00391.
  • Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010;56(3):486–495. doi: 10.1053/j.ajkd.2010.03.026.
  • Tsai JW, Cerdeña JP, Goedel WC, et al. Evaluating the impact and rationale of Race-Specific estimations of kidney function: estimations from U.S. NHANES, 2015-2018. EClinicalMedicine. 2021;42:101197. doi: 10.1016/j.eclinm.2021.101197.
  • New JP, Middleton RJ, Klebe B, et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med. 2007;24(4):364–369. doi: 10.1111/j.1464-5491.2007.02075.x.
  • Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007;298(17):2038–2047. doi: 10.1001/jama.298.17.2038.
  • Castro AF, Coresh J. CKD surveillance using laboratory data from the population-based national health and nutrition examination survey (NHANES). Am J Kidney Dis. 2009;53(3):S46–S55. doi: 10.1053/j.ajkd.2008.07.054.
  • Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: a sensitivity analysis using the national health and nutrition examination survey (NHANES) 1999-2004. Am J Kidney Dis. 2009;53(2):218–228. doi: 10.1053/j.ajkd.2008.07.034.
  • Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population > =40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591–1597. doi: 10.2337/diacare.27.7.1591.
  • Ostchega Y, Dillon CF, Lindle R, et al. Isokinetic leg muscle strength in older americans and its relationship to a standardized walk test: data from the national health and nutrition examination survey 1999-2000. J Am Geriatr Soc. 2004;52(6):977–982. doi: 10.1111/j.1532-5415.2004.52268.x.
  • Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12(11):1761–1768. doi: 10.1359/jbmr.1997.12.11.1761.
  • Li S, Zeng M. The association between dietary inflammation index and bone mineral density: results from the United States national health and nutrition examination surveys. Ren Fail. 2023;45(1):2209200. doi: 10.1080/0886022x.2023.2209200.
  • Heaney RP, Layman DK. Amount and type of protein influences bone health. Am J Clin Nutr. 2008;87(5):1567s–1570s. doi: 10.1093/ajcn/87.5.1567S.
  • Wallace TC. Optimizing dietary protein for lifelong bone health: a paradox unraveled. Nutr Today. 2019;54(3):107–115. doi: 10.1097/NT.0000000000000340.
  • Darling AL, Millward DJ, Torgerson DJ, et al. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr. 2009;90(6):1674–1692. doi: 10.3945/ajcn.2009.27799.
  • Wu A-M, Sun X-L, Lv Q-B, et al. The relationship between dietary protein consumption and risk of fracture: a subgroup and dose-response meta-analysis of prospective cohort studies. Sci Rep. 2015;5(1):9151. doi: 10.1038/srep09151.
  • Shams-White MM, Chung M, Du M, et al. Dietary protein and bone health: a systematic review and meta-analysis from the national osteoporosis foundation. Am J Clin Nutr. 2017;105(6):1528–1543. doi: 10.3945/ajcn.116.145110.
  • Dawson-Hughes B, Harris SS. Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women. Am J Clin Nutr. 2002;75(4):773–779. doi: 10.1093/ajcn/75.4.773.
  • Sahni S, Cupples LA, McLean RR, et al. Protective effect of high protein and calcium intake on the risk of hip fracture in the framingham offspring cohort. J Bone Miner Res. 2010;25(12):2770–2776. doi: 10.1002/jbmr.194.
  • Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913–921. doi: 10.2215/cjn.06040710.
  • Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;53(113):S1–S130. doi: 10.1038/ki.2009.188.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4):S1–S201.
  • Friedman EA. An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic kidney disease. Kidney Int Suppl. 2005;68(96):S2–S6. doi: 10.1111/j.1523-1755.2005.00448.x.
  • Fournier A, Morinière P, Ben Hamida F, et al. Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int Suppl. 1992;38:S50–S61.
  • Meric F, Yap P, Bia MJ. Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis. 1990;16(5):459–464. doi: 10.1016/s0272-6386(12)80059-x.
  • Kurz P, Monier-Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 1994;46(3):855–861. doi: 10.1038/ki.1994.342.
  • Zheng CM, Wu CC, Lu CL. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients. Int J Med Sci. 2019;16(12):1583. doi: 10.7150/ijms.39158.
  • Warnock DG. Uremic acidosis. Kidney Int. 1988;34(2):278–287. doi: 10.1038/ki.1988.177.
  • Bailey JL. Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease. Kidney Int Suppl. 2005;68(96):S15–S23. doi: 10.1111/j.1523-1755.2005.00450.x.
  • Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens. 2004;13(4):423–436. doi: 10.1097/01.mnh.0000133975.32559.6b.
  • Green J, Kleeman CR. Role of bone in regulation of systemic acid-base balance. Kidney Int. 1991;39(1):9–26. doi: 10.1038/ki.1991.2.
  • Lemann J, Jr., Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest. 1966;45(10):1608–1614. doi: 10.1172/jci105467.
  • Das P, Horton R. Physical activity-time to take it seriously and regularly. Lancet. 2016;388(10051):1254–1255. doi: 10.1016/s0140-6736(16)31070-4.
  • Chastin SF, Mandrichenko O, Helbostadt JL, et al. Associations between objectively-measured sedentary behaviour and physical activity with bone mineral density in adults and older adults, the NHANES study. Bone. 2014;64:254–262. doi: 10.1016/j.bone.2014.04.009.
  • Lourida I, Boer JMA, Teh R, et al. Association of daily physical activity and sedentary behaviour with protein intake patterns in older adults: a Multi-Study analysis across five countries. Nutrients. 2021;13(8):2574. doi: 10.3390/nu13082574.